These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 14630925)

  • 1. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.
    Roy M; Reiland J; Murry BP; Chouljenko V; Kousoulas KG; Marchetti D
    Neoplasia; 2005 Mar; 7(3):253-62. PubMed ID: 15799825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis.
    Roy M; Marchetti D
    J Cell Biochem; 2009 Feb; 106(2):200-9. PubMed ID: 19115257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
    Aucoin R; Reiland J; Roy M; Marchetti D
    J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases.
    Roskams T; Rosenbaum J; De Vos R; David G; Desmet V
    Hepatology; 1996 Sep; 24(3):524-32. PubMed ID: 8781318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
    Han J; Hiebert LM
    Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
    Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
    Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.
    Wang A; Miralem T; Templeton DM
    Metabolism; 1999 Oct; 48(10):1220-9. PubMed ID: 10535382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparan sulfate regulates targeting of syndecan-1 to a functional domain on the cell surface.
    Yang Y; Børset M; Langford JK; Sanderson RD
    J Biol Chem; 2003 Apr; 278(15):12888-93. PubMed ID: 12566461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.
    de Boer C; Armstrong Z; Lit VAJ; Barash U; Ruijgrok G; Boyango I; Weitzenberg MM; Schröder SP; Sarris AJC; Meeuwenoord NJ; Bule P; Kayal Y; Ilan N; Codée JDC; Vlodavsky I; Overkleeft HS; Davies GJ; Wu L
    Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2203167119. PubMed ID: 35881786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
    Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
    Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains.
    Kato M; Wang H; Bernfield M; Gallagher JT; Turnbull JE
    J Biol Chem; 1994 Jul; 269(29):18881-90. PubMed ID: 8034644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis.
    Patel VN; Knox SM; Likar KM; Lathrop CA; Hossain R; Eftekhari S; Whitelock JM; Elkin M; Vlodavsky I; Hoffman MP
    Development; 2007 Dec; 134(23):4177-86. PubMed ID: 17959718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
    Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
    Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
    Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
    Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate proteoglycan expression in human lung-cancer cells.
    Nackaerts K; Verbeken E; Deneffe G; Vanderschueren B; Demedts M; David G
    Int J Cancer; 1997 Jun; 74(3):335-45. PubMed ID: 9221815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
    Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
    J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.